Evaluation of Vepoloxamer in Chronic Heart Failure
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate whether vepoloxamer can provide a blood chemical
marker and functional benefit to damaged heart muscle cells. This will be evaluated by
measurement of blood-based laboratory markers, exercise tolerance, and echocardiograms. In
addition, the safety and blood levels of vepoloxamer in subjects with chronic heart failure
will be evaluated.